Reported Jun 19, 2024 · Ongoing
Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only,…
Pacira Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: PACIRA PHARMACEUTICALS INC · 10578 Science Center Dr · San Diego, CA · 92121-1143
Is this the product you have?
- Drug Vial LabelZilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only
- Manufactured forPacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01
- Diluent Vial LabelDiluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01
- Carton LabelDrug
- Vial LabelZilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only
- Manufactured forPacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01
- Lot codes and dates
- Lot082657 (kit 23-9004)
- ExpJuly 2024
- Amount recalled
- 43,768 kits
Where it was sold
- Nationwide
Why it was recalled
Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Pacira Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.